Document is current
Any future updates will be listed below
-
Authors
Li, Kexin
Pei, Yuqing
Dong, Xin
Wu, Yue
Lou, Xiaoying
Li, Yiling
Liang, Shuang
Wu, Yuxin
Xu, Danfei
Li, Bin
- License Information
-
More Information
Article History
Received: 29 June 2024
Revised: 23 January 2025
Accepted: 21 March 2025
First Online: 2 April 2025
Competing interests
: The authors declare no competing interests.
: All methods were performed in accordance with the relevant guidelines and regulations. Clinical studies were approved by the Ethics Committee of the Cancer Hospital of the Chinese Academy of Medical Sciences and Peking Union Medical College (approval number: NCC2020C-126; Beijing, China). All animal experiments were conducted in accordance with the guidelines of the Animal Research Ethics Committee of Cancer Hospital of the Chinese Academy of Medical Sciences and Peking Union Medical College (approval number: UJS-NCC2020A062; Beijing, China). Informed consent for participation in this study was obtained from the patients with OC.
